Extended Release Formulations of Anticonvulsant Medications: Clinical Pharmacokinetics and Therapeutic Advantages

ISSN： 1172-7047

Source： CNS Drugs, Vol.14, Iss.3, 2000-09, pp. : 203-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

By Maldonado Rafael

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1001-1014

Informa Healthcare

Access to resources Recommend Favorite

Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin

By Gayatri Sathyan

Clinical Pharmacokinetics, Vol. 43, Iss. 14, 2004-01 ,pp. : 1059-1068

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Gastrointestinal Tolerability of a Novel Extended-Release Microsphere Formulation of Azithromycin

By Chandra Richa Liu Ping Breen Jeanne D. Fisher Jeannine Xie Charles LaBadie Robert Benner Rebecca J. Benincosa Lisa J. Sharma Amarnath

Clinical Pharmacokinetics, Vol. 46, Iss. 3, 2007-01 ,pp. : 247-259

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Cytarabine Formulations

By Hamada A.

Clinical Pharmacokinetics, Vol. 41, Iss. 10, 2002-01 ,pp. : 705-718

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Once-Daily Molsidomine: From Immediate-Release to Prolonged-Release Once-Daily Formulations

By Herchuelz A.

American Journal of Drug Delivery, Vol. 2, Iss. 2, 2004-01 ,pp. : 131-141

Adis International

Access to resources Recommend Favorite